|
Health-related quality of life (HRQoL) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in combination with abiraterone. |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Johnson & Johnson; Novartis; Pfizer; Roche; Sanofi |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Johnson & Johnson; Novartis; Pfizer; Roche; Sanofi |
Research Funding - Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Johnson & Johnson; Pfizer; Roche |
|
|
Honoraria - Astellas Pharma; Ipsen; Pfizer |
Consulting or Advisory Role - Astellas Pharma; Ipsen; Pfizer |
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Pfizer |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi |
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi |
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi |
|
|
Consulting or Advisory Role - Pfizer; Sanofi |
|
|
Travel, Accommodations, Expenses - Merck |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen; Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen; Pfizer |
|
|
Consulting or Advisory Role - Abbvie; AstraZeneca; G1 Therapeutics; Merck |
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Janssen; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen; MSD; Pfizer; Roche; Roche; Sanofi |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
Employment - AstraZeneca; MSD |
Stock and Other Ownership Interests - AstraZeneca |
|
|
|
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
Travel, Accommodations, Expenses - AstraZeneca |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Sanofi |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Sanofi |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Janssen Oncology (Inst); Sanofi (Inst) |